You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

angiosarcoma

Showing 1 - 25 of 134
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Angiosarcoma Trial in Houston (Paclitaxel, mRNA plus Lysate-loaded Dendritic Cell Vaccine, PEGYLATED-INTERFERON ALPHA-2A)

Not yet recruiting
  • Angiosarcoma
  • Houston, Texas
    M D Anderson Cancer Center
Mar 23, 2023

Microvessel Ultrasound Imaging for Detecting Extent of Disease

Recruiting
  • Skin Angiosarcoma
  • Ultrasound Microvessel Imaging
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Feb 14, 2023

Locally Advanced Angiosarcoma, Metastatic Angiosarcoma, Recurrent Angiosarcoma Trial in Houston (Quality-of-Life Assessment,

Recruiting
  • Locally Advanced Angiosarcoma
  • +2 more
  • Quality-of-Life Assessment
  • Sintilimab
  • Houston, Texas
    M D Anderson Cancer Center
Jul 31, 2022

Malignant Melanoma, Angiosarcoma Trial in Chuo Ku (CICS-1 (investigational device),SPM-011(investigational drug))

Active, not recruiting
  • Malignant Melanoma
  • Angiosarcoma
  • CICS-1 (investigational device),SPM-011(investigational drug)
  • Chuo Ku, Tokyo, Japan
    National Cancer Center Hospital
Nov 6, 2022

Angiosarcoma Metastatic Trial in Guangzhou (Abraxane combined with liposomal doxorubicin)

Recruiting
  • Angiosarcoma Metastatic
  • Abraxane combined with liposomal doxorubicin
  • Guangzhou, Guangdong, China
    Xing Zhang
Sep 4, 2022

Unresectable Angiosarcoma Trial in Tokyo (BNCT)

Recruiting
  • Unresectable Angiosarcoma
  • BNCT
  • Tokyo, Japan
    National Cancer Center Hospital
Nov 21, 2022

Soft Tissue Sarcoma Adult, Angiosarcoma, Undifferentiated Pleomorphic Sarcoma Trial in Denmark, Norway, Sweden (Propranolol,

Recruiting
  • Soft Tissue Sarcoma Adult
  • +2 more
  • Aarhus, Denmark
  • +3 more
Jul 23, 2023

Angiosarcoma of Skin Trial in Worldwide (Oraxol)

Active, not recruiting
  • Angiosarcoma of Skin
  • New York, New York
  • +9 more
Jan 31, 2023

Angiosarcoma of Skin Trial in Tampa (T-VEC)

Active, not recruiting
  • Angiosarcoma of Skin
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Mar 22, 2022

Adult Angiosarcoma, Recurrent Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma Trial in United States (drug,

Completed
Has Results
  • Adult Angiosarcoma
  • +3 more
  • pazopanib hydrochloride
  • +4 more
  • Chicago, Illinois
  • +4 more
Jul 26, 2022

Angiosarcoma, Epithelioid Hemangioendothelioma Trial in Boston (Eribulin)

Recruiting
  • Angiosarcoma
  • Epithelioid Hemangioendothelioma
  • Boston, Massachusetts
  • +1 more
Feb 14, 2022

Angiosarcoma Trial in Amsterdam (Propranolol)

Recruiting
  • Angiosarcoma
  • Amsterdam, Netherlands
    Netherlands Cancer Institute - Antoni van Leeuwenhoek
Dec 20, 2021

Angiosarcoma Trial (AGEN2034, AGEN1884)

Withdrawn
  • Angiosarcoma
  • (no location specified)
Dec 21, 2021

Adult Angiosarcoma, Recurrent Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma Trial in United States

Completed
Has Results
  • Adult Angiosarcoma
  • +3 more
  • Santa Monica, California
  • +6 more
Mar 29, 2022

Angiosarcoma Trial in Austria, Germany (Pazopanib + Paclitaxel)

Terminated
Has Results
  • Angiosarcoma
  • Pazopanib + Paclitaxel
  • Graz, Austria
  • +9 more
Jan 21, 2022

SARCOMA Trial in New York, Houston (NKTR-214, Nivolumab)

Active, not recruiting
  • SARCOMA
  • New York, New York
  • +1 more
May 6, 2022

Sarcoma, Epithelioid Sarcoma, Cutaneous Angiosarcoma Trial in Stanford, New York (Talimogene Laherparepvec (T-VEC),

Recruiting
  • Sarcoma
  • +2 more
  • Stanford, California
  • +1 more
Feb 2, 2023

Secondary Angiosarcoma, Locally Advanced Sarcoma, Metastasis Trial in Nijmegen (Cemiplimab)

Recruiting
  • Secondary Angiosarcoma
  • +2 more
  • Nijmegen, Netherlands
    RadboudUMC
Jan 19, 2022

Advanced Soft Tissue Sarcoma, Locally Advanced Angiosarcoma, Locally Advanced Leiomyosarcoma Trial in Portland (Doxorubicin

Active, not recruiting
  • Advanced Soft Tissue Sarcoma
  • +26 more
  • Doxorubicin Hydrochloride
  • +3 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Jan 6, 2023

Metastatic Angiosarcoma, Metastatic Dedifferentiated Liposarcoma, Metastatic Osteosarcoma Trial in Houston (Durvalumab,

Recruiting
  • Metastatic Angiosarcoma
  • +7 more
  • Durvalumab
  • Oleclumab
  • Houston, Texas
    M D Anderson Cancer Center
Sep 21, 2021

Osteosarcoma, Bone Tumor, Bone Sarcoma Trial

Not yet recruiting
  • Osteosarcoma
  • +25 more
    • (no location specified)
    Aug 24, 2022

    Soft Tissue Sarcoma Trial in United Kingdom (Axitinib)

    Completed
    • Soft Tissue Sarcoma
    • Aberdeen, Scotland, United Kingdom
    • +12 more
    Mar 17, 2021

    Soft Tissue Sarcoma, Undifferentiated Pleomorphic Sarcoma, Myxofibrosarcoma Trial in Providence (Gemcitabine, 9-ING-41,

    Withdrawn
    • Soft Tissue Sarcoma
    • +12 more
    • Providence, Rhode Island
    • +1 more
    Nov 30, 2021

    Cutaneous Squamous Cell Carcinoma, SCC - Squamous Cell Carcinoma, Basal Cell Carcinoma Trial in United States (MQ719,

    Recruiting
    • Cutaneous Squamous Cell Carcinoma
    • +18 more
    • Basking Ridge, New Jersey
    • +6 more
    May 18, 2023

    Bone Sarcoma, Osteosarcoma, Ewing Sarcoma Trial in France (Treatment by Regorafenib, Treatment by Placebo)

    Recruiting
    • Bone Sarcoma
    • +6 more
    • Treatment by Regorafenib
    • Treatment by Placebo
    • Besançon, France
    • +15 more
    Aug 18, 2022